Foster City, CA, United States of America

Tao Sai

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2017)
  • Foster City, CA (US) (2012 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Tao Sai in Cancer Therapeutics**

Introduction

Tao Sai, based in Foster City, CA, is an accomplished inventor known for his significant contributions to the field of cancer therapeutics. With a portfolio of 15 patents, his work primarily focuses on innovative approaches to target malignancies through engineered immune responses. His discoveries have the potential to influence treatment strategies against various types of cancers.

Latest Patents

Among his latest patents, Tao Sai has developed chimeric antigen receptors (CARs) specifically targeting CD70. This innovation involves CARs that bind uniquely to CD70, creating engineered immune cells capable of recognizing and combating cancerous cells expressing this specific marker. Moreover, he has disclosed therapeutic methods utilizing these CARs and engineered immune cells to treat conditions associated with malignancies.

Another notable patent includes the provision of antibodies that also specifically target CD70. This invention encompasses both monospecific and bispecific antibodies, including those that interact with CD3 in addition to CD70. It further details the encoding nucleic acids for such antibodies and presents therapeutic applications for treating CD70-mediated pathologies, highlighting the relevance of his work in advancing cancer therapies.

Career Highlights

Throughout his career, Tao Sai has collaborated with prominent companies in the biotechnology and pharmaceutical sectors, including Morphotek, Inc. and Pfizer Corporation. His experiences at these organizations have empowered him to marry scientific innovation with practical application, enhancing the development of therapeutic solutions for patients.

Collaborations

Tao has worked alongside distinguished colleagues in the field, including Philip M. Sass and Nicholas C. Nicolaides. These collaborations have undoubtedly enriched his research, fostering a creative environment that drives progress in developing cutting-edge therapies.

Conclusion

With his extensive patent portfolio and innovative ideas, Tao Sai continues to be a vital player in the realm of cancer research. His contributions toward chimeric antigen receptors and specific antibodies underline the importance of targeted therapies, setting a foundation for future advancements in both academic and clinical settings.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…